BNGO News and Press, Bionano Genomics Inc. From 09/07/21

SAN DIEGO and SHANGHAI, China, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that NuProbe Global, a global molecular diagnostics company based in Shanghai, China and Houston, Texas, has adopted Bionano’s Saphyr system for optical genome mapp...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips 2021 has been an exciting year for BioNano Genomics (NASDAQ: BNGO ) investors. However, when it comes to stocks, excitement can cut both ways. A spectacular run started last Christmas eve. It saw BNGO stock go from be...

SAN DIEGO, Aug. 26, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the European Society of Human Genetics (ESHG) conference lineup featuring 11 customer presentations of optical genome mapping (OGM) data spanning three major clinical areas of application from...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Bionano  (NASDAQ: BNGO ) stock has more going for it than many people may recognize. Among the most exciting is a financial incentive plan for its Saphyr genome mapping system. Source: Natali_ Mis/ShutterStock....

BNGO remains a speculative trade after Q2 revenue fails to give a solid signal of the medical community's acceptance of Saphyr. The mediocre performance is by no means a thesis for shorting the ticker, given the company's robust balance sheet and commercial opportunity for Saphyr. ...

Bionano Genomics (NASDAQ:BNGO) jumped over 6% on Thursday after the company reported ~226% YoY revenue growth in Q2 2021, a historical high for a second quarter. After three consecutive quarters of decline, the revenue growth has gradually accelerated over the past three quarte...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips There’s no denying that shares of life sciences company Bionano Genomics  (NASDAQ: BNGO ) aren’t as cheap as they were in 2020. Yet, due to a recent price pullback, BNGO stock is more attractive than...

Image source: The Motley Fool. Bionano Genomics, Inc (NASDAQ: BNGO) Q2 2021 Earnings Call Aug 04, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Bionano Genomics, Inc (BNGO) Q2 2021 Earnings Call Transcript

Bionano Genomics, Inc. (BNGO) Q2 2021 Earnings Conference Call August 4, 2021 4:30 PM ET Company Participants Amy Conrad – Investor Relations Erik Holmlin – Chief Executive Officer Alka Chaubey – Chief Medical Officer Chris Stewart – Chief Financial Officer Confere...

Bionano Genomics (NASDAQ:BNGO) shares rise nearly 4% post market after reporting second-quarter revenue that beat Wall Street estimates, helped by the momentum in the cytogenetics market. The company's chief executive officer Chris Stewart called the quarterly results "very pos...